Hemophilia B: all 275 studies

Page 2 of 3. Open to participants first (52), then studies with results posted, then the rest; newest registration first within each.

• Efficacy and Safety of NNC 0078-0000-0007 in Patients With Congenital Haemophilia and InhibitorsCompletedNCT01392547Phase 3Results posted
• Efficacy and Safety of NNC-0156-0000-0009 During Surgical Procedures in Subjects With Haemophilia BCompletedNCT01386528Phase 3Results posted
• A Safety and Efficacy Study of a Recombinant Factor IX in Patients With Severe Hemophilia BCompletedNCT01361126Phase 1/2Results posted
• Study To Compare On-Demand Treatment To A Prophylaxis Regimen Of BeneFIX In Subjects With Moderately Severe to Severe Hemophilia BCompletedNCT01335061Phase 3Results posted
• Safety and Efficacy of NNC-0156-0000-0009 in Haemophilia B PatientsCompletedNCT01333111Phase 3Results posted
• BAX 326 (rFIX) Continuation StudyCompletedNCT01286779Phase 3Results posted
• Study of Recombinant Factor IX Product, IB1001, in Previously Treated Pediatric Subjects With Hemophilia BTerminatedNCT01271868Phase 3Results posted
• Pivotal Study (Pharmacokinetics, Efficacy, Safety) of BAX 326 (rFIX) in Hemophilia B PatientsCompletedNCT01174446Phase 3Results posted
• BeneFIX Drug Use Results Survey [All-Case Surveillance]CompletedNCT01154231Results posted
• Study of Recombinant Factor IX Fc Fusion Protein (rFIXFc) in Participants With Hemophilia BCompletedNCT01027364Phase 3Results posted
• Study of Ataluren (PTC124) in Hemophilia A and BTerminatedNCT00947193Phase 2Results posted
• Study Evaluating Liver Transplantation in Haemophilia Patients in SpainCompletedNCT00927992Results posted
• PROPACT: Retrospective Prophylaxis Patient Case CollectionCompletedNCT00882778Results posted
• Study Evaluating On-Demand Treatment With BeneFIX In Chinese SubjectsCompletedNCT00866606Phase 3Results posted
• Efficacy and Safety Study of Prophylactic Versus On-Demand Treatment With Feiba NF in Subjects With Hemophilia A or B and a High Titer InhibitorCompletedNCT00851721Phase 3Results posted
• Post Marketing Observational Study of Reformulated BeneFIXCompletedNCT00835068Results posted
• Study of Recombinant Factor IX Product, IB1001, in Subjects With Hemophilia BCompletedNCT00768287Phase 2/3Results posted
• Study Evaluating BeneFIX in Patients With Haemophilia B, Previously Treated With Plasma Derived Factor IXCompletedNCT00749476Phase 4Results posted
• Registry For Patients Treated With BeneFix In Usual Care Setting In GermanyCompletedNCT00714415Results posted
• Observational Registry of NovoSeven® Used as On-demand Treatment of Bleeds in Patients With Haemophilia A and B With InhibitorsCompletedNCT00703911Results posted
• Haemophilia Patients With Inhibitors Being Treated for Acute Joint BleedsCompletedNCT00486278Phase 2Results posted
• Post Marketing Surveillance To Observe Safety and Efficacy Of BeneFIX In Patients With Hemophilia BCompletedNCT00484185Results posted
• Study Comparing On-Demand Treatment With Two Prophylaxis Regimens Of BeneFIX In Patients With Severe Hemophilia BCompletedNCT00364182Phase 3Results posted
• Effect of Non-Surgical Periodontal Treatment on Oral Health in Hemophilia PatientsCompletedNCT07691437Not applicable
• Validity and Reliability of the Two-minute Step Test in HemophiliaCompletedNCT07425327
• Data Registry in Chinese Hemophilia A and B PatientsCompletedNCT07101224
• Patient Interview Study to Explore the Impact of Gene Therapy in Hemophilia A & BWithdrawnNCT06634836
• BeCoMe-9: A Clinical Study of BE-101 for the Treatment of Adults With Moderately Severe or Severe Hemophilia BTerminatedNCT06611436Phase 1/2
• The Long-term Safety and Efficacy of SerpinPC in Subjects with Hemophilia Who Completed a Sponsored SerpinPC Clinical TrialTerminatedNCT06568302Phase 3
• Recombinant Fusion Protein Linking Coagulation Factor IX With Albumin (rIX-FP) in Chinese Subjects With Hemophilia B Previously Treated With FIX TherapyCompletedNCT06399289Phase 3
• Study of TU7710 in Warfarin Anti-coagulated Healthy Male SubjectsCompletedNCT06025552Phase 1
• SS109 and NovoSeven ® PK / PD Profile, and Preliminary Efficacy and Safety of SS109 on Demand TreatmentCompletedNCT06010953Phase 1/2
• Reliability and Validity of the Turkish Version of the PedHALStatus unknownNCT05889754
• Comparison of Efficiency of Closed Kinetic Chain Exercises Versus Proprioceptive Exercises Patient With HemophiliaCompletedNCT05879549Not applicable
• Vitamin K Antagonist Versus Direct Oral Anticoagulant Treatments in HemophiliaCompletedNCT05804734
• A Study of SerpinPC in Participants with Hemophilia B (HemB) with InhibitorsTerminatedNCT05789537Phase 2
• The Efficacy and Safety of SerpinPC in Participants with Severe Hemophilia a or Moderately Severe to Severe Hemophilia BTerminatedNCT05789524Phase 2
• Baby Detect : Genomic Newborn ScreeningCompletedNCT05687474
• A Phase I of SS109 in Hemophilia A or and B With InhibitorsCompletedNCT05651061Phase 1
• Gaining Insight Into the Complexity of Pain in Patients With HaemophiliaCompletedNCT05606640
• Hemophilia Non-Interventional Study Prior to SerpinPC Intervention (PRESent-5)TerminatedNCT05605678
• A Trial That Evaluates Disease Characteristics in Hemophilia B Adult Male Participants Receiving Prophylaxis With Standard of Care Factor IX Protein (FIX) Replacement TherapyActive, not recruitingNCT05568459
• Clinical Study of Recombinant Human Activated Coagulation Factor VII for Injection in Patients With Hemophilia With InhibitorStatus unknownNCT05487976Phase 3
• Lead-in Study of VGB-R04 Gene Therapy for Hemophilia B-- An Observational Survey Analysis StudyStatus unknownNCT05442528
• A Study to Evaluate the Safety and Efficacy of VGB-R04 in Adult Hemophilia B PatientsStatus unknownNCT05441553Phase 1/2
• Validation and Reliability of the CHO-KLAT in TurkishStatus unknownNCT05439642Not applicable
• Study of AAV5-hFIX in Severe or Moderately Severe Haemophilia BCompletedNCT05360706
• Evaluation of the Safety and Efficacy of Hemophilia B Gene Therapy DrugActive, not recruitingNCT05203679Phase 2/3
• Pre-clinical Models for Mesenchymal Stem Cell Therapy in Hemophilic ArthropathyStatus unknownNCT05187936
• Observatory of Patients With Haemophilia B Treated by IdElvion®Active, not recruitingNCT05086575
• Needs Assessment of Knowledge, Beliefs, and Attitudes of Patients With Hemophilia B About Gene TherapyCompletedNCT05044845
• Study on the Dose-response Relationship of Pharmacodynamic Parameters in Patients With Hemophilia With InhibitorsCompletedNCT04789954Early Phase 1
• Study of Recombinant Human Coagulation Factor VIIa for Injection (FⅦa) in Patients With Hemophilia.Status unknownNCT04768699Phase 1
• Psychometric Validation of the Hemophilia Functional Ability Scoring Tool (Hemo-FAST)CompletedNCT04731701
• Long Term Follow-up (LTFU) of Subjects Who Received SB-318, SB-913, or SB-FIXTerminatedNCT04628871
• Dosage and PD Study of Eftrenonacog-alfaCompletedNCT04590950
• Medication Adherence and Non-adherence in Adults With Rare DiseaseWithdrawnNCT04541875
• Factor In the Initial Resuscitation of Severe Trauma 2 PatientsTerminatedNCT04534751Phase 4
• Study of Coagulation Factor VIIa Marzeptacog Alfa (Activated) in Subjects With Hemophilia A or BTerminatedNCT04489537Phase 3
• AAV Gene Therapy Screening/Observational Protocol (ECLIPSE)CompletedNCT04272554
• Gene Therapy for Chinese Hemophilia BCompletedNCT04135300Not applicable
• The Effectiveness of Recombinant Coagulation Factor IX With Recombinant Albumin (rIX-FP) in Severe Hemophilia B PatientsStatus unknownNCT04108260Phase 4
• A Study of Factor Inhibitors in Adult Patients With Hemophilia and Von Willebrand's Disease in Upper EgyptStatus unknownNCT04106323
• The Safety and Tolerability of SerpinPC in Healthy Men and in Men with Severe Blood Disorders (haemophilia a and B)CompletedNCT04073498Phase 1/2
• Mutation p.Ile112Thr : Discrepancy Between Factor IX Level and Bleeding PhenotypeStatus unknownNCT03946384
• An International Study to Evaluate the Real-world Effectiveness and Usage of Alprolix in Patients With Haemophilia BCompletedNCT03901755
• Post-marketing Surveillance (Use Result Surveillance) With Refixia®CompletedNCT03875547
• ATHN 8: Previously Untreated Patients (PUPs) Matter StudyCompletedNCT03818529
• A Study Following People With Haemophilia A and B, With or Without Inhibitors, When on Usual Treatment (Explorer™6)CompletedNCT03741881
• A Study of the Impact of Hemophilia and Its Treatment on Brain Development, Thinking and Behaviour in Children With HemophiliaCompletedNCT03660774
• A Study to Evaluate the Real-world Effectiveness and Usage of Alprolix in Patients With Haemophilia B in FranceCompletedNCT03655340
• Early Check: Expanded Screening in NewbornsActive, not recruitingNCT03655223
• A Long-Term Follow-Up Study of Haemophilia B Patients Who Have Undergone Gene TherapyTerminatedNCT03641703Phase 1/2
• ATHN 7: Hemophilia Natural History StudyCompletedNCT03619863
• Personalized Medicine for Canadians With HemophiliaStatus unknownNCT03615053Not applicable
• Web Accessible Population Pharmacokinetics Service - Hemophilia: Sources of VariabilityStatus unknownNCT03533504
• Virtual Reality for HemophiliaCompletedNCT03507582Not applicable
• A Study to Assess Pharmacokinetics and Pharmacodynamics Following Administration of BAY1093884 in Patients With Severe HemophiliaCompletedNCT03481946Phase 1
• Awareness, Care, and Treatment In Obesity Management of Patients With Hemophilia (ACTION) to Inform Hemophilia Obesity Patient Empowerment (HOPE)CompletedNCT03430154
• Prospective, Non-interventional Study to Evaluate Immunogenicity of AryoSevenCompletedNCT03372993
• Joint Health StudyCompletedNCT03358836
• Long-term Safety and Efficacy Study and Dose-Escalation Substudy of PF 06838435 in Individuals With Hemophilia BTerminatedNCT03307980Phase 2
• Management of Health-Related QoL Impairment, Including Pain, Depression and Anxiety, in People With Haemophilia A and BCompletedNCT03276130
• Global Epidemiologic Study of Preexisting Immunity to AAV in Adults With Severe HemophiliaCompletedNCT03185897
• A Trial Comparing Nonacog Beta Pegol (N9-GP) and ALPROLIX® in Patients With Haemophilia BCompletedNCT03075670Phase 1
• A Study to Evaluate the Real-world Usage and Effectiveness of Elocta and Alprolix in Patients With Haemophilia A or BCompletedNCT03055611
• Non-Interventional Study to Capture the Patient Experience on Gene Therapy for Hemophilia Within the AskBio009-101 Study Through Patient and Investigator InterviewsCompletedNCT03054389
• Long-Term Safety, Tolerability, and Efficacy of DTX101 (AAVrh10FIX) in Adults With Moderate/Severe to Severe Hemophilia BCompletedNCT02971969
• UK - EHL Outcomes RegistryStatus unknownNCT02938156
• Post-Marketing Surveillance (Usage Results Study) of RIXUBIS in Adult and Pediatric Patients With Haemophilia B in South KoreaCompletedNCT02922231
• The Hemophilia Ultrasound ProjectTerminatedNCT02807753
• Factor Product Utilization and Health Outcomes in Patients With HemophiliaCompletedNCT02796222
• Ultrasonography in Hemophilic Joint Disease and Serum MarkersCompletedNCT02634918
• A Single Escalating Dose and Multiple Dose Study of BAY 1093884 in Subjects With Severe Hemophilia Types A or B, With or Without InhibitorsCompletedNCT02571569Phase 1
• Bridging Hemophilia B Experiences, Results and Opportunities Into Solutions (B-HERO-S)CompletedNCT02568202
• Natural History Study of Factor IX Treatment and ComplicationsStatus unknownNCT02502409
• Study of Recombinant Factor VIIa Fusion Protein (rVIIa-FP, CSL689) for On-demand Treatment of Bleeding Episodes in Patients With Hemophilia A or B With InhibitorsTerminatedNCT02484638Phase 2/3
• A Study of a Long-Acting r-Factor 7a (Factor VIIa) in Adult Men With Hemophilia A or BCompletedNCT02418793Phase 1
• A Study Comparing Factor Level and Inhibitor Titer Testing Results Drawn From Central Venous Lines and VenipunctureTerminatedNCT02402829
• Fc factOrs and Real-World hemophiliA Patient-ReporteD OutcomesTerminatedNCT02392156

← Hemophilia B overview